Mink Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $-11,708,192 |
Gross Profit | -45 | -53 | -11,708,245 |
EBITDA | -2,856 | -3,776 | -5,446 |
EBIT | -2,901 | -3,829 | -5,500 |
Net Income | -2,701 | -3,813 | -5,459 |
Net Change In Cash | 0 | 0 | -11,708,192 |
Free Cash Flow | -2,290 | -2,542 | -2,962 |
Cash | 9,313 | 5,817 | 3,367 |
Basic Shares | 37,142 | 34,642 | 34,558 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $2,704,743 | $0 | $0 |
Gross Profit | -204 | -28,244,535 | -28,358,591 | -55 |
EBITDA | -22,253 | -30,827 | -27,703 | -13,742 |
EBIT | -22,457 | -30,949 | -27,781 | -13,797 |
Net Income | -22,457 | -24,779 | -23,114 | -15,678 |
Net Change In Cash | 0 | 2,704,743 | 0 | 0 |
Cost of Revenue | -19,272 | |||
Free Cash Flow | -15,836 | -19,116 | -13,076 | -8,432 |
Cash | 3,367 | 19,635 | 38,888 | 2,691 |
Basic Shares | 34,359 | 33,672 | 33,476 | 33,087 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.05 |
2024-06-30 | -$0.07 |
2024-03-31 | -$0.11 |
2023-12-31 | -$0.16 |
